AnalystsMatthew CaufieldMatthew Caufield's Stock Forecasts
AnalystsMatthew Caufield
Analyst Ranking
Bottom 1%
#4934 out of 4953 analysts
Average Return
-15.79%
Win Rate
35%50 out of 144
Risk vs Reward
Poor
Good
Matthew Caufield's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Phathom Pharmaceuticals IncPHAT | +212.32% | $2.76 | $8.62 | 2025-05-01 - 2025-07-29 | Buy |
Aldeyra Therapeutics IncALDX | +169.31% | $1.89 | $5.09 | 2025-04-03 - 2025-07-29 | Buy |
Oyster Point Pharma IncOYST | +149.89% | $4.47 | $11.17 | 2022-07-17 - 2023-01-03 | Buy |
Aldeyra Therapeutics IncALDX | +110.33% | $2.42 | $5.09 | 2025-05-18 - 2025-07-29 | Buy |
Zenas Biopharma IncZBIO | +95.49% | $8.21 | $16.05 | 2025-03-11 - 2025-07-29 | Buy |
Matthew Caufield Analyst Color
Get additional color on Matthew Caufield's coverage of popular stocks
Matthew Caufield's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Lenz Therapeutics IncLENZ | 6 | Buy | $48.00 | +51.56% | Maintains | 3 days ago |
Diamedica Therapeutics IncDMAC | 6 | Buy | $12.00 | +161.44% | Maintains | 13 days ago |
Opus Genetics IncIRD | 13 | Buy | $8.00 | +601.75% | Reiterates | a month ago |
Ardelyx IncARDX | 1 | Buy | $10.00 | +136.97% | Assumes | a month ago |
Mineralys Therapeutics IncMLYS | 9 | Buy | $42.00 | +202.59% | Reiterates | a month ago |
Lyra Therapeutics IncLYRA | 7 | Hold | $16.00 | +120.39% | Maintains | 2 months ago |
Phathom Pharmaceuticals IncPHAT | 10 | Buy | $20.00 | +132.02% | Reiterates | 2 months ago |
Akebia Therapeutics IncAKBA | 1 | Buy | $8.00 | +127.92% | Assumes | 2 months ago |
Unity Biotechnology IncUNBX | 9 | Hold | $2.00 | +900.00% | Downgrades | 2 months ago |
Tarsus Pharmaceuticals IncTARS | 1 | Buy | $72.00 | +79.37% | Assumes | 2 months ago |
Optinose IncOPTN | 8 | Hold | $9.00 | -6.25% | Reiterates | 2 months ago |
Aldeyra Therapeutics IncALDX | 13 | Buy | $10.00 | +96.46% | Reiterates | 2 months ago |
Zenas Biopharma IncZBIO | 3 | Buy | $30.00 | +86.92% | Reiterates | 2 months ago |
Adverum Biotechnologies IncADVM | 6 | Buy | $30.00 | +1,114.57% | Reiterates | 3 months ago |
Surrozen IncSRZN | 3 | Buy | $32.00 | +245.95% | Reiterates | 3 months ago |
Immunic IncIMUX | 4 | Buy | $10.00 | +921.45% | Reiterates | 3 months ago |
Fibrobiologics IncFBLG | 4 | Buy | $12.00 | +1,876.94% | Reiterates | 4 months ago |
Hillevax IncHLVX | 5 | Hold | $2.00 | -5.21% | Reiterates | 4 months ago |
Kodiak Sciences IncKOD | 4 | Hold | $3.00 | -61.54% | Reiterates | 4 months ago |
Opthea LtdOPT | 7 | Hold | $2.00 | -41.35% | Downgrades | 4 months ago |
Hyperion Defi IncHYPD | 16 | Hold | $2.00 | -77.17% | Reiterates | 4 months ago |
4d Molecular Therapeutics IncFDMT | 18 | Buy | $36.00 | +725.69% | Reiterates | 5 months ago |
FabrinetFN | 1 | Buy | $28.00 | N/A | Reiterates | 2 years ago |
Iveric Bio IncISEE | 6 | Hold | $40.00 | N/A | Downgrades | 2 years ago |
Oyster Point Pharma IncOYST | 1 | Buy | $20.00 | N/A | Initiates Coverage On | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.